Ca-19-9, A new marker for gastrointestinal malignancy

descriptionPublicationkeyboard_double_arrow_right Article 01 Oct 1985 English Publisher:Springer Science and Business Media LLCJournal:Irish Journal of Medical Science, volume 154, pages 385-386 (issn: 0021-1265, eissn: 1863-4362,

Copyright policy )

Authors: M J, Duffy; F, O'Sullivan; D, O'Donoghue; N H, Afdhal; D, Kelleher;

doi: 10.1007/bf02937186

pmid: 3865919

Ca-19-9, A new marker for gastrointestinal malignancy

- Summary
- Subjects
- Metrics

Abstract

Ca-19-9 and CEA were measured in serum from patients with a variety of malignancies. Ca-19-9 was elevated in 97% of 30 patients with pancreatic carcinoma and 53% of 15 patients with gastric carcinomas. The main advantage of Ca-19-9 over CEA as a marker for gastrointestinal malignancy is the low number of false positive elevations in patients with benign gastrointestinal disease. It is concluded that Ca-19-9 is the best presently available biochemical marker for cancer of the pancreas.

Related Organizations

St. Vincent's Health System
United States
St. James's Hospital
Ireland

Keywords

Antigens, Neoplasm, Humans, Antigens, Tumor-Associated, Carbohydrate, Carcinoembryonic Antigen, Gastrointestinal Neoplasms

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	3
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average